Westside Investment Management, Inc.
Position in EVFM — Evofem Biosciences, Inc.
CIK 1538383
SANTA MONICA, CA
Position in EVFM
as of Sep 30, 2022
· filed Nov 9, 2022
Position Value
$0
-$11,300 QoQ
Shares Held
5
-93.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EVFM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Westside Investment Management, Inc. holds $2,010,329 across 24 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KZIA |
Kazia Therapeutics Ltd
|
47,585 | $669,996 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
6,140 | $334,875 | |
| 3 | LTRN |
Lantern Pharma Inc.
|
47,850 | $199,534 | |
| 4 | INMB |
Inmune Bio, Inc.
|
108,300 | $176,529 | |
| 5 | ANIX |
Anixa Biosciences Inc
|
43,000 | $120,400 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
181 | $112,860 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
179 | $88,914 | |
| 8 | ARGX |
Argenx SE
|
60 | $55,666 |
All Filings in EVFM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2022-09-30 | — | 666 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $11,300 | 10,000 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,399 | 10,000 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,759 | 10,000 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $7,389 | 10,000 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $11,299 | 10,000 | Shares | Sole | 2021-07-28 | |
| 2020-12-31 | $137 | 57 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $134 | 57 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $161 | 57 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||